International Patent: TARGETING IL1R1, MEOX1, AND MAFF FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE

GENEVA, June 19 -- THE CHILDREN'S MEDICAL CENTER CORPORATION filed a patent application (US2025/055598) for “TARGETING IL1R1, MEOX1, AND MAFF FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE”. With publication no. WO/2026/107366, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 39/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....